Fasken Martineau DuMoulin LLP advised Debiopharm Innovation Fund in the transaction.Altis Labs Inc. announced the closing of its C$7.9 million ($6 Million) seed funding round co-led by Debiopharm…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
